Inform your strategy with a single source of truth using competitive intelligence pharma databases.

Make data-driven decisions
Predict granular drug phase shifts and probabilities of success in the U.S., Europe and Asia with Drug Timeline & Success Rates, an AI-based analytical tool. Validate your own predictions using a data-driven reference that includes historical overview benchmarks.

Forecast with confidence
Benchmark your forecasts using a unique combination of thousands of drug consensus forecasts coupled with proprietary Cortellis drug sales analysis. Gain granularity by exploring forecasts by region, therapy, drug brand, or drug group or subgroups.

Access integrated insights
A seamless gateway to regulatory, drug discovery, clinical trial, deals, and generics intelligence, with direct links and single sign-on making it easy to find related content. Their data is also available via APIs or data feeds.

Funding Information:
Clarivate Analytics has raised a total of $94M in funding over 4 rounds. Their latest funding was raised on Nov 15, 2022 from a Post-IPO Equity round.